Urology Billing Services

We bill for urology practices where office procedures, drugs and surgery share one schedule.

• General urology groups: same-day cystoscopy, catheter and bladder scan work, where modifier 25 and NCCI bundling decide what pays.
• Uro-oncology practices: prostate biopsy under the 2026 codes, bladder tumor resection coded by size, BCG instillations and androgen deprivation injections billed by the milligram.
• BPH and stone practices: urethral lift, water vapor therapy, laser enucleation, ureteroscopy and stents across office, ASC and hospital.
• Female urology and pelvic health: urodynamics, bladder Botox, sacral neuromodulation and incontinence devices that need payer approval.
• Men's health and APP-staffed clinics: vasectomy, testosterone care, and nurse practitioner or PA visits billed under the right NPI.

Service lines we bill alongside the physician claims: in-office drug administration, urodynamics and ultrasound, in-house pathology and urinalysis, ASC facility claims, and self-pay vasectomy estimates through patient billing.

Urology revenue leaks at the procedure and drug line more than at the visit. Scenarios we check first, priced at 2026 Medicare national rates for non-APM clinicians.

Denials and short payments like these are worked through denials and AR recovery, oldest money first.

Cystoscopy carries most urology office procedure revenue and most bundling edits. These medical coding rules come from CPT, the NCCI Policy Manual and the 2026 fee schedule.

2026 Medicare national rates for common cystoscopy codes

Non-APM rates, rounded. NA means Medicare sets no office rate.

Rules that decide whether the line pays

• Diagnostic is included in surgical. When a diagnostic cystoscopy leads to a surgical cystoscopy at the same encounter, only the surgical code is reported. It stays separately reportable only when it leads to an open or laparoscopic procedure.
• 52332 means a stent left in place. A temporary stent inserted and removed during the case is not reported with 52332, and 52332 and 52005 are not reported for the same ureter at the same encounter.
• 52356 already includes the stent. Ureteroscopic lithotripsy with a stent on the same side is 52356, not 52353 plus 52332.
• Tumor size belongs in the note. 52234, 52235 and 52240 are chosen by size, so the operative note needs a measurement in centimeters.
• Laterality. Codes with Medicare bilateral indicator 1 go on one line with modifier 50 at 150% payment; check the indicator before using RT and LT.

On January 1, 2026, CPT deleted 55700 and replaced it with prostate biopsy codes that describe approach, guidance and targeting. Imaging guidance is now part of the code: 76872 and 76942 can no longer be billed with any prostate biopsy code. MRI post-processing (76376, 76377) can still be reported when the radiologist has not billed it.

2026 prostate biopsy codes and Medicare national rates

BPH procedure billing

• Prostatic urethral lift: 52441 for the first implant ($1,245 office, $184 facility, 0-day global) and 52442 for each additional implant ($864 office), with a Medicare unit limit of 6 on 52442. A seven-implant case is 52441 once plus 52442 six times.
• Water vapor therapy: 53854 pays $3,398 in the office and $354 in a facility. CGS billing article A56083 covers it for FDA-cleared indications.
• Laser procedures: 52648 photoselective vaporization ($528) and 52649 laser enucleation ($657) are facility-only.
• Approvals: UnitedHealthcare Medicare Advantage requires prior authorization for 52441 and 52442 in 2026, so eligibility and prior authorization comes before booking.

Medical billing for urology drug administration

Medicare pays most Part B drugs at average sales price plus 6%, updated each quarter, so the unit count on the drug line sets the payment.

• JW and JZ: on single-dose containers, report discarded drug on its own line with JW, or add JZ when nothing was discarded. JZ has been required since July 1, 2023, and claims without the modifiers can be returned as unprocessable.

Urodynamics coding

• 51728 (complex cystometrogram with voiding pressure studies) and 51729 (the same with urethral pressure profile) are alternatives, not a pair.
• Add-on 51797 (intra-abdominal voiding pressure) is billed only with 51728 or 51729, without modifier 51.
• 51741 complex uroflowmetry and 51784 sphincter EMG are separate lines.
• Post-void residual by ultrasound (51798) and urodynamics carry MAC coverage rules, such as CGS LCDs L34085 and L34056, that set the documentation required.

A 2026 prostate biopsy can still go out as 55700 plus ultrasound

The rule: 55700 was deleted on January 1, 2026 (AUA summary of the CY 2026 fee schedule final rule), and the new codes include imaging, so 76872 and 76942 are not billed with them (Focal Therapy Society coding update). The cost: $342 per rejected 55707 office claim. Our finding: 12% of prostate biopsy claims from January to June 2026 still used 55700 or a separate ultrasound guidance code.

Any visit on a cystoscopy day can carry modifier 25

The rule: 52000 has a 0-day global period, and when the decision to do a minor procedure comes right before it, the visit is routine pre-procedure work. Only a significant, separately identifiable problem supports modifier 25 (CMS Global Surgery Booklet). The cost: the visit line, plus recoupment on audit. Our finding: Same-day E/M visits with an in-office cystoscopy were denied for modifier 25 on 13% of claims.

Drug units follow the number of injections

The rule: J9217 is billed per 7.5 mg and J9155 per 1 mg, and JZ is required on single-dose containers with nothing discarded (CMS JW and JZ modifier FAQs). The cost: a 22.5 mg leuprolide dose billed as 1 unit collects a third of the drug payment. Our finding: Drug units did not match the administered dose on 8% of urology injection claims.

A nurse practitioner can see new urology patients incident-to

The rule: incident-to needs the physician to perform the initial service, with direct supervision after that (Medicare Benefit Policy Manual, Chapter 15, section 60). A new patient seen by an NP bills under the NP's own NPI at 85% of the fee schedule (Claims Processing Manual, Chapter 12, section 120). The cost: recoupment of the 15% difference on every affected claim, so finish credentialing first. Our finding: Credentialing lapses delayed payment for 1 in 12 providers added in the prior year.

Urology practices run an EHR plus separate drug, urodynamics and imaging records. We work inside what you have, with no migration. That matters: 38% had changed EHR or practice management system in the past five years, and 71% said collections dipped for at least six months after the switch (Luxen Practice Manager Survey 2026).

• EHR and PM: ModMed EMA Urology, athenahealth, eClinicalWorks, NextGen, AdvancedMD, UroChartEHR and Epic.
• Procedure and drug records: in-office drug administration logs, Laborie urodynamics reports, bladder scan and ultrasound images, reconciled against charges.
• Pathology and lab: in-house pathology and urinalysis results matched to the ordering visit and diagnosis.

From 4,600 urology claims in the Luxen claim audit, Jan 2025 to Jun 2026:

• Same-day E/M visits with an in-office cystoscopy were denied for modifier 25 on 13% of claims.
• Tumor size was missing from the operative note on 9% of bladder tumor resection claims.
• Drug units did not match the administered dose on 8% of urology injection claims.
• 12% of prostate biopsy claims from January to June 2026 still used 55700 or a separate ultrasound guidance code.

Luxen charges 3% to 6% of collections, set by claim volume, service mix and aged AR. Month to month, 30 days notice, no setup or exit fee.

What urology medical billing services cost at 3% to 6%

Example: a four-provider urology group with in-office procedures and drug administration, collecting $125,000 a month.

The in-house column uses our finding that fully loaded in-house billing cost 7.9% of collections for practices under $2M, across 96 practices that shared payroll data: $118,500 a year against $45,000 to $90,000 with Luxen, before vacancies. Open biller roles took a median 67 days to fill.

Questions to ask a urology billing company

• Which 2026 prostate biopsy codes do you use, and what stops 76872 from going out with them?
• How do you check tumor size, stent side and diagnostic-with-surgical cystoscopy before submission?
• Who reconciles leuprolide, degarelix and BCG units against the administration record, with JW or JZ?
• What do you report monthly on modifier 25 denials and underpayments, and what is your fee basis?

In our 2026 survey of 286 practice managers, 44% could not name the fee basis in their current billing contract, and 52% of practices that switched billing vendors cited missing denial reporting as the main reason.

How urology billing partners compare

Compare medical billing companies in your state before you sign.

• CMS, CY 2026 Medicare Physician Fee Schedule final rule fact sheet (CMS-1832-F)
• AUA, Final rule CY 2026 Medicare Physician Fee Schedule summary
• ASH, CY 2026 Medicare Physician Fee Schedule final rule summary (efficiency adjustment and facility practice expense)
• CMS, CY 2027 Medicare Physician Fee Schedule proposed rule fact sheet
• Cystoscopy-Based Procedures 2026 Coding and Payment Quick Reference (national rates at the $33.4009 conversion factor)
• Stone Management Procedures 2026 Coding and Payment Quick Reference
• Prostate Health 2026 Coding and Payment Quick Reference
• Prostate Biopsy 2026 Coding and Payment Quick Reference
• Focal Therapy Society, 2026 prostate biopsy billing and coding updates
• A Guide to Physician Billing for the Prostatic Urethral Lift Procedure, January 2026 (52441, 52442, MUE)
• NCCI Policy Manual for Medicare Services 2026, Chapter VII
• CMS MLN907166, Global Surgery Booklet
• CMS Medicare Claims Processing Manual, Chapter 12
• CMS Medicare Benefit Policy Manual, Chapter 15
• CMS, JW and JZ modifier FAQs
• CMS, JW and JZ modifier policy HCPCS code list (J9217, J9155, J0585)
• CMS, Part B drug payment limits overview (ASP plus 6%)
• CMS Medicare Coverage Database, billing article A56754, intravesical BCG (J9030 per 1 mg)
• CMS Medicare Coverage Database, billing article A56083, water vapor thermal therapy (53854)
• CMS Medicare Coverage Database, LCD L34056 urodynamics
• CMS Medicare Coverage Database, LCD L34085 post-void residual urine by ultrasound
• Laborie, urodynamics coding reference (51728, 51729, 51797)
• UnitedHealthcare Medicare Advantage prior authorization requirements, effective January 1, 2026
• CMS, Interoperability and Prior Authorization final rule fact sheet (CMS-0057-F)
• CMS, WISeR model
• CMS, WISeR Provider and Supplier Operational Guide
• Luxen claim audit: 61,400 claims audited, Jan 2025 to Jun 2026. Luxen billing reviews: 410 practice billing reviews, Jan 2025 to Jun 2026. Luxen client data: 38 client practices, Jan 2024 to Jun 2026. Luxen Practice Manager Survey 2026: 286 practice managers, March 2026.